Cephapirin Pregnancy and Breastfeeding Warnings
Cephapirin is also known as: Cefadyl
Cephapirin Pregnancy Warnings
There are no reports of adverse effects of cephapirin on the human fetus. Cephapirin is known to cross the human placenta. In one study of 30 women who were given cephapirin 1 gram intramuscularly, the average peak umbilical cord and amniotic fluid cephapirin levels were 10.4 (four hours after dosing) and 13.0 (six hours after dosing) mcg/mL, respectively.
Cephapirin has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Cephapirin should only be given during pregnancy when need has been clearly established.
Cephapirin Breastfeeding Warnings
Cephapirin is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.
In one report of six women who were given cephapirin 1 gram intravenously, the average peak milk level was 0.49 mcg/mL between one and two hours after dosing. The average milk to maternal plasma cephapirin level ratios were 0.068, 0.250, and 0.480 at 1, 2, and 3 hours after dosing, respectively. While these levels are low, some experts warn of the unknown direct effects on the nursing infant, modification of neonatal bowel flora, and difficulty in the interpretation of culture results in the evaluation of a suspected infection.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.